Oncotelic Therapeutics OTC Stock Forecast - Accumulation Distribution
| OTLC Stock | USD 0.07 0.01 7.00% |
Oncotelic OTC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Oncotelic Therapeutics stock prices and determine the direction of Oncotelic Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Oncotelic Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the value of rsi of Oncotelic Therapeutics' share price is below 20 . This indicates that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Oncotelic Therapeutics based on different types of headlines from major news networks to social media. Using Oncotelic Therapeutics hype-based prediction, you can estimate the value of Oncotelic Therapeutics from the perspective of Oncotelic Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Oncotelic Therapeutics after-hype prediction price | USD 0.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Oncotelic |
Oncotelic Therapeutics Additional Predictive Modules
Most predictive techniques to examine Oncotelic price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oncotelic using various technical indicators. When you analyze Oncotelic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 1600.0 | 22824.35 |
| Check Oncotelic Therapeutics Volatility | Backtest Oncotelic Therapeutics | Information Ratio |
Oncotelic Therapeutics Trading Date Momentum
| On January 23 2026 Oncotelic Therapeutics was traded for 0.07 at the closing time. The top price for the day was 0.08 and the lowest listed price was 0.07 . The trading volume for the day was 135.1 K. The trading history from January 23, 2026 did not cause price change. The trading delta at closing time against the current closing price is 8.20% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Oncotelic Therapeutics to competition |
Other Forecasting Options for Oncotelic Therapeutics
For every potential investor in Oncotelic, whether a beginner or expert, Oncotelic Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncotelic OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncotelic. Basic forecasting techniques help filter out the noise by identifying Oncotelic Therapeutics' price trends.Oncotelic Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncotelic Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Oncotelic Therapeutics could also be used in its relative valuation, which is a method of valuing Oncotelic Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oncotelic Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Oncotelic Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncotelic Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncotelic Therapeutics otc stock market strength indicators, traders can identify Oncotelic Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 22824.35 | |||
| Daily Balance Of Power | (0.41) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.0737 | |||
| Day Typical Price | 0.0739 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0.01) |
Oncotelic Therapeutics Risk Indicators
The analysis of Oncotelic Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncotelic Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncotelic otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.61 | |||
| Standard Deviation | 6.84 | |||
| Variance | 46.78 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Oncotelic Therapeutics
The number of cover stories for Oncotelic Therapeutics depends on current market conditions and Oncotelic Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oncotelic Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oncotelic Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Oncotelic OTC Stock
Oncotelic Therapeutics financial ratios help investors to determine whether Oncotelic OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncotelic with respect to the benefits of owning Oncotelic Therapeutics security.